Effect of Inhaled TD-8236 on Allergen-induced Asthmatic Response
Clinical trial NCT04150341 · COMPLETED
Trial details
- NCT number
- NCT04150341
- Sponsor
- Theravance Biopharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-06
- Primary completion
- 2020-08-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.